Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative blood biomarkers.
DBI | F
Overview
Corporate Details
- ISIN(s):
- DE000A0Z25L1
- LEI:
- 391200BIDNL2ZOKI1M61
- Country:
- Germany
- Address:
- Neuendorfstraße 15a, 16761 Hennigsdorf
- Website:
- https://www.dbi-ag.de/
- Sector:
- Manufacturing
Description
Deutsche Biotech Innovativ AG is a biotechnology company focused on the research and clinical development of therapeutic solutions for serious diseases. The company utilizes innovative blood biomarkers to guide its development process. Its lead product candidate is Adrecizumab, a monoclonal, adrenomedullin-specific antibody designed to treat conditions involving endothelial barrier dysfunction. Adrecizumab has completed Phase I/II clinical trials for the treatment of septic shock.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-08-16 17:04 |
Deutsche Biotech Innovativ AG: Kapitalerhohung
|
German | 7.8 KB | ||
| 2017-08-11 16:31 |
Deutsche Biotech Innovativ AG: Portfolio-Unternehmen Adrenomed erhalt Genehmigu…
|
German | 7.6 KB | ||
| 2017-08-10 00:00 |
Datum:10.08.2017
|
German | 57.2 KB | ||
| 2017-03-08 13:34 |
Deutsche Biotech Innovativ AG: Sepsis-Medikament der Adrenomed AG erweist sich …
|
German | 8.5 KB | ||
| 2016-06-02 14:21 |
Deutsche Biotech Innovativ AG: - Adrenomed AG startet Klinische Phase mit Sepsi…
|
German | 8.3 KB | ||
| 2016-03-22 15:04 |
Deutsche Biotech Innovativ AG: Anteil der DBI AG an der AdrenoMed AG steigt auf…
|
German | 3.5 KB | ||
| 2015-11-25 11:32 |
Deutsche Biotech Innovativ AG invests funds from capital increase in clinical d…
|
English | 5.2 KB | ||
| 2015-10-29 17:07 |
Deutsche Biotech Innovativ AG: First public offer to private investors
|
English | 10.1 KB | ||
| 2015-10-09 10:50 |
Deutsche Biotech Innovativ AG: Deutsche Biotech Innovativ AG launches capital i…
|
English | 12.7 KB | ||
| 2015-09-25 12:26 |
Deutsche Biotech Innovativ AG: Subscrition price for capital increase against c…
|
English | 6.7 KB | ||
| 2015-09-09 10:46 |
Deutsche Biotech Innovativ AG: First Berlin starts coverage with EUR 67.90 pric…
|
English | 6.4 KB | ||
| 2015-08-06 10:54 |
Deutsche Biotech Innovativ AG: Sepsis drug Adrecizumab shows high degree of eff…
|
English | 8.2 KB | ||
| 2015-07-24 12:39 |
Deutsche Biotech Innovativ AG: AGM approves bonus shares and capital increase
|
English | 5.5 KB | ||
| 2015-07-21 10:05 |
Deutsche Biotech Innovativ AG: Significant strengthening of the patent protecti…
|
English | 5.5 KB | ||
| 2015-06-12 16:31 |
Deutsche Biotech Innovativ AG: Successful further development of sepsis and can…
|
English | 6.8 KB |
Automate Your Workflow. Get a real-time feed of all Deutsche Biotech Innovativ AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Deutsche Biotech Innovativ AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Deutsche Biotech Innovativ AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
